Karolinska Fund

PHASEIN introduces a radically new, ultra-small and clinically significant gas monitoring solution for use within intensive care, anesthesia and emergency care.

MEDICA is the number one global meeting point for the medical sector and every year the fair hosts exhibitors from over 60 countries as well as visitors from almost 100 countries. PHASEIN illustrates the simplicity and convenience of the IRMA probes with the help of a Pocket PC, converting the handheld unit into a multi-gas monitor. "The launch of the IRMA probe at the MEDICA industry trade fair in Düsseldorf is the result of our 25 years of expertise and tradition developing gas analysis systems and marks a new era in gas monitoring," says PHASEIN CEO Robert Zyzanski.

For further information, please contact:
Robert Zyzanski, CEO,
phone: +46 8 544 98 166, +46 708 733 326
robert.zyzanski@phasein.se / www.phasein.se



NEWS, Karolinska Investment Fund


December 29, 2003: NsGene NsGene A/S raises DKK 18 million in a second round of financing from existing investors December 10, 2003: Sidec Technologies Sidec Technologies takes a major step into the US market for structure based drug design, through alliance with The Center for Biophysical Sciences and Engineering, Birmingham, AL December 8, 2003: Sidec Technologies Successful launch makes Sidec Technologies extend its board and focus entirely on biotech supply November 19, 2003: PHASEIN PHASEIN launches the world´s smallest multi-gas analyzer - the IRMA™ probe at MEDICA 2003 November 19, 2003: PHASEIN IRMA™ ultra-small gas monitoring probes convert a Pocket PC into a multi-gas monitor November 3, 2003: Accuro Immunology Accuro Immunology AB selects first candidate drug October 22, 2003: Demetech AB Osteoporosis diagnosis revolutionized October 8, 2003: Cellectricon Cellectricon AB and Axon Instruments Collaborate on New Transfection Technology August 28, 2003: Sidec Technologies Sidec in collaboration with The Cleveland Clinic August 20, 2003: Big Pharma Big Pharma orders prove successful commercial launch for DynaflowTM August 7, 2003: Gyros Gyros s launches Gyrolab Bioaffy at Drug Discovery and Technology, Boston June 10, 2003: Demetech New evaluation study of the DXL technology published June 4, 2003: Gyros Gyros introduces new CD microlaboratory for Gyrolab MALDI users May 20, 2003: Sidec Technologies Sidec Technologies takes on new owners April 9, 2003: NsGene NsGene A/S obtains an exclusive license to encapsulated cell technology (ECT) for the nervous system. February 20, 2003: Sidec Technologies Sidec sign contract with Procognia

Karolinska Fund - News